Nicola Origlia

Institute of Neuroscience

H指数:31

被引数:2,845

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Chemogenetic manipulation of learning-tagged neurons is sufficient to rescue progressive memory deficits in a mouse model of Alzheimer's disease

化学遗传操控标记的学习神经元足以挽救阿尔茨海默病小鼠模型中的进行性记忆缺陷

Alzheimer's & Dementia

IF0

2025-11-270

OAAI

Involvement of a lateral entorhinal cortex engram in episodic-like memory recall

CELL REPORTS

IF6.9

2024-10-010

PRE

New Insights into the LANCL2-ABA Binding Mode towards the Evaluation of New LANCL Agonists

PHARMACEUTICS

IF5.5

2023-12-123

OAAI

Microglial extracellular vesicles induce Alzheimer's disease-related cortico-hippocampal network dysfunction

BRAIN COMMUNICATIONS

IF4.5

2023-05-313

OAAI

Editorial: Loss of taste and smell in COVID-19 patients: A prognostic tool and a starting point to investigate the action of SARS-CoV-2 in the central nervous system

FRONTIERS IN CELLULAR NEUROSCIENCE

IF4

2023-04-031

OAAI

Emerging Roles of Extracellular Vesicles in Alzheimer's Disease: Focus on Synaptic Dysfunction and Vesicle-Neuron Interaction

细胞外囊泡在阿尔茨海默病中的新兴作用: 关注突触功能障碍和囊泡-神经元相互作用

CELLS

IF5.2

2022-12-2311

OAAI

Microglial large extracellular vesicles propagate early synaptic dysfunction in Alzheimer's disease

小胶质细胞大细胞外囊泡在阿尔茨海默病中传播早期突触功能障碍

BRAIN

IF11.7

2022-03-0353

OAAI

T1AM-TAAR1 signalling protects against OGD-induced synaptic dysfunction in the entorhinal cortex

T1AM-TAAR1信号可防止OGD诱导的内嗅皮层突触功能障碍

NEUROBIOLOGY OF DISEASE

IF5.6

2021-04-017

OAAI

Smell and Taste in Severe CoViD-19: Self-Reported vs. Testing

严重新型冠状病毒肺炎的嗅觉和味觉: 自我报告与测试

FRONTIERS IN MEDICINE

IF3

2020-12-0252

OAAI

Endogenous 3-Iodothyronamine (T1AM) and Synthetic Thyronamine-Like Analog SG-2 Act as Novel Pleiotropic Neuroprotective Agents through the Modulation of SIRT6

MOLECULES

IF4.6

2020-02-2615

OAAI

Exogenous 3-Iodothyronamine Rescues the Entorhinal Cortex from β-Amyloid Toxicity

外源性3-碘代thyronamine从 β-淀粉样蛋白毒性中拯救了内嗅皮层

THYROID

IF6.7

2020-01-0121

OAAI

Current Limitations in the Treatment of Parkinson's and Alzheimer's Diseases: State-of-the-Art and Future Perspective of Polymeric Carriers

CURRENT MEDICINAL CHEMISTRY

IF3.5

2019-01-3142

PRE

An isoform-selective p38α mitogen-activated protein kinase inhibitor rescues early entorhinal cortex dysfunctions in a mouse model of Alzheimer's disease

NEUROBIOLOGY OF AGING

IF3.5

2018-10-0126

OAAI

Overexpression of endophilin A1 exacerbates synaptic alterations in a mouse model of Alzheimer's disease

NATURE COMMUNICATIONS

IF15.7

2018-07-3037

OAAI

Entorhinal Cortex dysfunction can be rescued by inhibition of microglial RAGE in an Alzheimer's disease mouse model

SCIENTIFIC REPORTS

IF3.9

2017-02-1365

OAAI

The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor

BRAIN

IF11.7

2016-12-2840

OAAI

Clinical correlates of plasma brain-derived neurotrophic factor in post-traumatic stress disorder spectrum after a natural disaster

PSYCHIATRY RESEARCH

IF3.9

2016-10-0125

PREAI

In vivo study of the role of α6-containing nicotinic acetylcholine receptor in retinal function using subtype-specific RDP-MII(E11R) toxin

FASEB JOURNAL

IF4.2

2016-09-281

PREAI

INTRANASAL BUT NOT INTRAPARENCHIMAL DELIVERY OF PAINLESS NERVE GROWTH FACTOR RESCUES MEMORY DEFICITS IN A MOUSE MODEL OF ALZHEIMER'S DISEASE BY TARGETING GLIAL CELLS AND REDUCING AMYLOID DEPOSITION THROUGH ENHANCEMENT OF NEURONAL SDF-1α

NEUROBIOLOGY OF AGING

IF3.5

2016-03-010

PREAI

BDNF prevents amyloid-dependent impairment of LTP in the entorhinal cortex by attenuating p38 MAPK phosphorylation

NEUROBIOLOGY OF AGING

IF3.5

2015-03-0164

PREAI

Nicola Origlia

个人简介

教育背景

工作经历

荣誉奖项

研究方向